Decoquinate is 4-hydroxy quinolone agent that has anticoccidial activity. Decoquinate acts on the sporozoite stage of the life cycle. The sporozoite apparently can still penetrate the host intestinal cell, but further development is prevented. The mechanism of action for decoquinate is to disrupt electron transport in the mitochondrial cytochrome system of coccidia.
Deferoxamine is used for the treatment of either acute or chronic iron toxicity. It is being evaluated as an iron chelator for adjunctive treatment of acute cardiac ischemia and as a chelator for aluminum toxicity. Its efficacy in treating reperfusion injuries has been disappointing.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
腎功能調整：Extend interval in renal impairment
腎功能調整：Extend interval in renal impairment
腎功能調整：Extend interval in renal impairment
腎功能調整：Extend interval in renal impairment
Decoquinate 的數值必須同時綁定精確產品濃度與密度、飼料或乳品基質、物種、生產類別、寄生蟲與生活史階段、預防／治療／形上治療／復發抑制目的、法域及食品動物停藥與乳蛋限制。犬美洲肝簇蟲病是長期復發抑制且須接在初期多藥療程之後；犬球蟲預防 50 mg/kg、llama 條目及腎功能延長間隔均未獲本輪足夠現行公開證據。系統目前無上述門檻，故不得產生通用劑量、茶匙換算或飼主／生產者自行配藥指示。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）